2026 Independent Medical Education Request for Proposals
Roche's 2026 Independent Medical Education RFP funds educational programs advancing knowledge of KRAS G12C-positive NSCLC for U.S. community oncology teams.
Funder: Roche
Due Dates: September 16, 2026: Full grant proposal submission deadline
Funding Amounts: Up to $225,000 per grant; funding supports independent CME/CE education activities.
Summary: Supports independent medical education to advance knowledge and practice in KRAS G12C-positive non-small cell lung cancer for U.S. community oncology teams.
Key Information: Only U.S.-based, accredited CME/CE providers with a gFRS account are eligible.
Description
This opportunity, issued by Genentech's Independent Medical Education team (a Roche Group member), seeks applications from accredited U.S.-based educational providers to deliver independent, certified medical education (CME/CE) activities. The 2026 focus is on the rapidly evolving landscape of KRAS G12C-positive non-small cell lung cancer (NSCLC), targeting the educational needs of community oncologists and multidisciplinary cancer teams. Funded activities should address knowledge and practice gaps related to new therapies and advances in KRAS G12C+ NSCLC, ultimately aiming to improve patient outcomes through evidence-based education.
